Skip to main navigation Skip to search Skip to main content

Functional comparison of recombinant interleukin 2 (IL-2) with IL-2-containing preparations derived from cultured cells

Research output: Contribution to journal › Article › peer-review

Abstract

Due to its purity and potential availability in large amounts, human recombinant interleukin 2 (IL-2) expressed in Escherichia coli is an important source of IL-2 for experimentation and possible therapy. To date, very few comparisons between the activity of recombinant IL-2 and conventional cell-derived preparations of IL-2 have been made. This is particularly important since the use of recombinant IL-2 may have some specific limitations. For example, recombinant IL-2 is not post-translationally modified as are cell-derived preparations. Lack of modifications such as glycosylation of threonine 3 may alter efficacy or stability. Comparative studies are necessary to demonstrate the efficacy, species specificity, and stability of recombinant IL-2. By comparing IL-2 activity of recombinant IL-2 to that of cell-derived IL-2, we have demonstrated that each of the preparations are equally active in several murine and human IL-2 proliferation assays and that IL-2 is the active moiety in these assays. In contrast to previous reports, we also show that recombinant IL-2 is sufficient to establish and maintain long-term cell lines. Additionally, by using "synthetic" recombinant IL-2 of defined protein sequence, we have demonstrated that this amino acid-defined structure is indeed responsible for the functions attributed to IL-2.

Original languageEnglish (US)
Pages (from-to)146-156
Number of pages11
JournalCellular Immunology
Volume95
Issue number1
DOIs
StatePublished - Oct 1 1985
Externally publishedYes

Funding

We thank V. Paetkaua nd C. Havele for providingt he 2.8.2a nd 9.27 cell lines, R. Miller for the ELd-derivedI L-2, BiogenR esearchC orp. for the rIL-2, and J. Lee for performingt he colony assaysT. his work wass upportedb y the MedicalR esearchC ouncil of Canada,t heN ationalC ancerI nstitutea, nd the Muscular DystrophyF oundation.G . Mills is a recipiento f an AlbertaH eritageT rust Fund fellowship.

Funders
AlbertaH eritageT rust Fund

    ASJC Scopus subject areas

    • Immunology

    Fingerprint

    Dive into the research topics of 'Functional comparison of recombinant interleukin 2 (IL-2) with IL-2-containing preparations derived from cultured cells'. Together they form a unique fingerprint.

    Cite this